KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onto Innovation (ONTO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Onto Innovation (ONTO) over the last 16 years, with Q3 2025 value amounting to $603.1 million.

  • Onto Innovation's Cash & Equivalents rose 21953.55% to $603.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $603.1 million, marking a year-over-year increase of 21953.55%. This contributed to the annual value of $212.9 million for FY2024, which is 880.61% down from last year.
  • Onto Innovation's Cash & Equivalents amounted to $603.1 million in Q3 2025, which was up 21953.55% from $217.5 million recorded in Q2 2025.
  • Onto Innovation's Cash & Equivalents' 5-year high stood at $603.1 million during Q3 2025, with a 5-year trough of $126.4 million in Q1 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $190.9 million (2024), whereas its average is $210.3 million.
  • In the last 5 years, Onto Innovation's Cash & Equivalents crashed by 2304.77% in 2024 and then surged by 21953.55% in 2025.
  • Onto Innovation's Cash & Equivalents (Quarter) stood at $152.2 million in 2021, then grew by 15.55% to $175.9 million in 2022, then surged by 32.77% to $233.5 million in 2023, then decreased by 8.81% to $212.9 million in 2024, then soared by 183.21% to $603.1 million in 2025.
  • Its Cash & Equivalents stands at $603.1 million for Q3 2025, versus $217.5 million for Q2 2025 and $203.7 million for Q1 2025.